Verition Fund Management LLC Coherus Bio Sciences, Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $24,700 - $59,809	-15,535 Reduced 25.31%	45,854 $152,000
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $39,270 - $57,225	10,500 Added 20.63%	61,389 $229,000
Q2 2023 Aug 14, 2023	BUY	$3.79 - $8.3 $6,822 - $14,940	1,800 Added 3.67%	50,889 $217,000
Q1 2023 May 15, 2023	BUY	$5.89 - $10.52 $289,134 - $516,416	49,089 New	49,089 $335,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $76,511 - $148,006	10,671 New	10,671 $103,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.